The study identifies key symptoms like abdominal pain and hematochezia as significant indicators of early-onset colorectal cancer and stresses the importance of early diagnosis to improve survival rates.
Amgen touts new data for drug MariTide, moving rapidly into Phase 3 work
Amgen said that an interim look at a Phase 2 trial of its anti-obesity drug MariTide had left the company “very encouraged,” and it planned